Pancreatic Ductal AdenocarcinomaФаза 2NCT07199764
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
Odetiglucan, Mitazalimab
28 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Pancreas28 studies
Pancreatic Ductal AdenocarcinomaФаза 2NCT07199764
Odetiglucan, Mitazalimab
Pancreatic Ductal Adenocarcinoma (mPDAC)Фаза 2NCT06790602Papers
Cemiplimab Plus Gemcitabine
Metastatic Pancreatic Ductal Adenocarcinoma (Second Line)Phase 1/2NCT06904378
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1NCT06639724Papers
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer